首页> 美国卫生研究院文献>other >Screening for Intellectual Disability Using High-Resolution CMA Technology in a Retrospective Cohort from Central Brazil
【2h】

Screening for Intellectual Disability Using High-Resolution CMA Technology in a Retrospective Cohort from Central Brazil

机译:来自巴西中部的回顾性队列研究使用高分辨率CMA技术筛查智力障碍

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intellectual disability is a complex, variable, and heterogeneous disorder, representing a disabling condition diagnosed worldwide, and the etiologies are multiple and highly heterogeneous. Microscopic chromosomal abnormalities and well-characterized genetic conditions are the most common causes of intellectual disability. Chromosomal Microarray Analysis analyses have made it possible to identify putatively pathogenic copy number variation that could explain the molecular etiology of intellectual disability. The aim of the current study was to identify possible submicroscopic genomic alterations using a high-density chromosomal microarray in a retrospective cohort of patients with otherwise undiagnosable intellectual disabilities referred by doctors from the public health system in Central Brazil. The CytoScan HD technology was used to detect changes in the genome copy number variation of patients who had intellectual disability and a normal karyotype. The analysis detected 18 CNVs in 60% of patients. Pathogenic CNVs represented about 22%, so it was possible to propose the etiology of intellectual disability for these patients. Likely pathogenic and unknown clinical significance CNVs represented 28% and 50%, respectively. Inherited and de novo CNVs were equally distributed. We report the nature of CNVs in patients from Central Brazil, representing a population not yet screened by microarray technologies.
机译:智力障碍是一种复杂,多变的异质性疾病,代表世界范围内诊断出的残疾状况,其病因是多种多样且高度异质的。微观染色体异常和特征明确的遗传状况是智力障碍的最常见原因。染色体微阵列分析分析使鉴定可能致病的拷贝数变异成为可能,该变异可解释智力障碍的分子病因。本研究的目的是在巴西中部公共卫生系统的医生转介的原本无法诊断的智障患者的回顾性队列中,使用高密度染色体微阵列鉴定可能的亚显微基因组改变。 CytoScan HD技术用于检测智障和正常核型患者的基因组拷贝数变异。该分析在60%的患者中检测出18个CNV。病原性CNV约占22%,因此有可能提出这些患者智力障碍的病因。 CNV可能具有致病性和未知的临床意义,分别占28%和50%。继承的CNV和从头开始的CNV平均分配。我们报告了来自巴西中部(代表尚未通过微阵列技术筛选的人群)患者的CNV的性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号